BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27732966)

  • 1. HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer.
    Ross-Adams H; Ball S; Lawrenson K; Halim S; Russell R; Wells C; Strand SH; Ørntoft TF; Larson M; Armasu S; Massie CE; Asim M; Mortensen MM; Borre M; Woodfine K; Warren AY; Lamb AD; Kay J; Whitaker H; Ramos-Montoya A; Murrell A; Sørensen KD; Fridley BL; Goode EL; Gayther SA; Masters J; Neal DE; Mills IG
    Oncotarget; 2016 Nov; 7(46):74734-74746. PubMed ID: 27732966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.
    Shen H; Fridley BL; Song H; Lawrenson K; Cunningham JM; Ramus SJ; Cicek MS; Tyrer J; Stram D; Larson MC; Köbel M; ; Ziogas A; Zheng W; Yang HP; Wu AH; Wozniak EL; Woo YL; Winterhoff B; Wik E; Whittemore AS; Wentzensen N; Weber RP; Vitonis AF; Vincent D; Vierkant RA; Vergote I; Van Den Berg D; Van Altena AM; Tworoger SS; Thompson PJ; Tessier DC; Terry KL; Teo SH; Templeman C; Stram DO; Southey MC; Sieh W; Siddiqui N; Shvetsov YB; Shu XO; Shridhar V; Wang-Gohrke S; Severi G; Schwaab I; Salvesen HB; Rzepecka IK; Runnebaum IB; Rossing MA; Rodriguez-Rodriguez L; Risch HA; Renner SP; Poole EM; Pike MC; Phelan CM; Pelttari LM; Pejovic T; Paul J; Orlow I; Omar SZ; Olson SH; Odunsi K; Nickels S; Nevanlinna H; Ness RB; Narod SA; Nakanishi T; Moysich KB; Monteiro AN; Moes-Sosnowska J; Modugno F; Menon U; McLaughlin JR; McGuire V; Matsuo K; Adenan NA; Massuger LF; Lurie G; Lundvall L; Lubiński J; Lissowska J; Levine DA; Leminen A; Lee AW; Le ND; Lambrechts S; Lambrechts D; Kupryjanczyk J; Krakstad C; Konecny GE; Kjaer SK; Kiemeney LA; Kelemen LE; Keeney GL; Karlan BY; Karevan R; Kalli KR; Kajiyama H; Ji BT; Jensen A; Jakubowska A; Iversen E; Hosono S; Høgdall CK; Høgdall E; Hoatlin M; Hillemanns P; Heitz F; Hein R; Harter P; Halle MK; Hall P; Gronwald J; Gore M; Goodman MT; Giles GG; Gentry-Maharaj A; Garcia-Closas M; Flanagan JM; Fasching PA; Ekici AB; Edwards R; Eccles D; Easton DF; Dürst M; du Bois A; Dörk T; Doherty JA; Despierre E; Dansonka-Mieszkowska A; Cybulski C; Cramer DW; Cook LS; Chen X; Charbonneau B; Chang-Claude J; Campbell I; Butzow R; Bunker CH; Brueggmann D; Brown R; Brooks-Wilson A; Brinton LA; Bogdanova N; Block MS; Benjamin E; Beesley J; Beckmann MW; Bandera EV; Baglietto L; Bacot F; Armasu SM; Antonenkova N; Anton-Culver H; Aben KK; Liang D; Wu X; Lu K; Hildebrandt MA; ; ; Schildkraut JM; Sellers TA; Huntsman D; Berchuck A; Chenevix-Trench G; Gayther SA; Pharoah PD; Laird PW; Goode EL; Pearce CL
    Nat Commun; 2013; 4():1628. PubMed ID: 23535649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk.
    Painter JN; O'Mara TA; Batra J; Cheng T; Lose FA; Dennis J; Michailidou K; Tyrer JP; Ahmed S; Ferguson K; Healey CS; Kaufmann S; Hillman KM; Walpole C; Moya L; Pollock P; Jones A; Howarth K; Martin L; Gorman M; Hodgson S; ; ; De Polanco MM; Sans M; Carracedo A; Castellvi-Bel S; Rojas-Martinez A; Santos E; Teixeira MR; Carvajal-Carmona L; Shu XO; Long J; Zheng W; Xiang YB; ; Montgomery GW; Webb PM; Scott RJ; McEvoy M; Attia J; Holliday E; Martin NG; Nyholt DR; Henders AK; Fasching PA; Hein A; Beckmann MW; Renner SP; Dörk T; Hillemanns P; Dürst M; Runnebaum I; Lambrechts D; Coenegrachts L; Schrauwen S; Amant F; Winterhoff B; Dowdy SC; Goode EL; Teoman A; Salvesen HB; Trovik J; Njolstad TS; Werner HM; Ashton K; Proietto T; Otton G; Tzortzatos G; Mints M; Tham E; ; Hall P; Czene K; Liu J; Li J; Hopper JL; Southey MC; ; Ekici AB; Ruebner M; Johnson N; Peto J; Burwinkel B; Marme F; Brenner H; Dieffenbach AK; Meindl A; Brauch H; ; Lindblom A; Depreeuw J; Moisse M; Chang-Claude J; Rudolph A; Couch FJ; Olson JE; Giles GG; Bruinsma F; Cunningham JM; Fridley BL; Børresen-Dale AL; Kristensen VN; Cox A; Swerdlow AJ; Orr N; Bolla MK; Wang Q; Weber RP; Chen Z; Shah M; French JD; Pharoah PD; Dunning AM; Tomlinson I; Easton DF; Edwards SL; Thompson DJ; Spurdle AB
    Hum Mol Genet; 2015 Mar; 24(5):1478-92. PubMed ID: 25378557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-Generation Sequencing Approach in Methylation Analysis of HNF1B and GATA4 Genes: Searching for Biomarkers in Ovarian Cancer.
    Bubancova I; Kovarikova H; Laco J; Ruszova E; Dvorak O; Palicka V; Chmelarova M
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HNF1B and JAZF1 genes, diabetes, and prostate cancer risk.
    Stevens VL; Ahn J; Sun J; Jacobs EJ; Moore SC; Patel AV; Berndt SI; Albanes D; Hayes RB
    Prostate; 2010 May; 70(6):601-7. PubMed ID: 19998368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HNF1B-mediated repression of SLUG is suppressed by EZH2 in aggressive prostate cancer.
    Wang J; He C; Gao P; Wang S; Lv R; Zhou H; Zhou Q; Zhang K; Sun J; Fan C; Ding G; Lan F
    Oncogene; 2020 Feb; 39(6):1335-1346. PubMed ID: 31636385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale fine mapping of the HNF1B locus and prostate cancer risk.
    Berndt SI; Sampson J; Yeager M; Jacobs KB; Wang Z; Hutchinson A; Chung C; Orr N; Wacholder S; Chatterjee N; Yu K; Kraft P; Feigelson HS; Thun MJ; Diver WR; Albanes D; Virtamo J; Weinstein S; Schumacher FR; Cancel-Tassin G; Cussenot O; Valeri A; Andriole GL; Crawford ED; Haiman C; Henderson B; Kolonel L; Le Marchand L; Siddiq A; Riboli E; Travis RC; Kaaks R; Isaacs W; Isaacs S; Wiley KE; Gronberg H; Wiklund F; Stattin P; Xu J; Zheng SL; Sun J; Vatten LJ; Hveem K; Njølstad I; Gerhard DS; Tucker M; Hayes RB; Hoover RN; Fraumeni JF; Hunter DJ; Thomas G; Chanock SJ
    Hum Mol Genet; 2011 Aug; 20(16):3322-9. PubMed ID: 21576123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cumulative evidence for relationships between multiple variants of HNF1B and the risk of prostate and endometrial cancers.
    Tong Y; Qu Y; Li S; Zhao F; Wang Y; Mu D
    BMC Med Genet; 2018 Jul; 19(1):128. PubMed ID: 30053805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in LMTK2, MSMB and HNF1B gene expression are associated with the development of prostate cancer.
    Harries LW; Perry JR; McCullagh P; Crundwell M
    BMC Cancer; 2010 Jun; 10():315. PubMed ID: 20569440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HNF1B, EZH2 and ECI2 in prostate carcinoma. Molecular, immunohistochemical and clinico-pathological study.
    Dundr P; Bártů M; Hojný J; Michálková R; Hájková N; Stružinská I; Krkavcová E; Hadravský L; Kleissnerová L; Kopejsková J; Hiep BQ; Němejcová K; Jakša R; Čapoun O; Řezáč J; Jirsová K; Franková V
    Sci Rep; 2020 Sep; 10(1):14365. PubMed ID: 32873863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HNF1B inhibits cell proliferation via repression of SMAD6 expression in prostate cancer.
    Lu W; Sun J; Zhou H; Wang F; Zhao C; Li K; Fan C; Ding G; Wang J
    J Cell Mol Med; 2020 Dec; 24(24):14539-14548. PubMed ID: 33174391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative bioinformatics links HNF1B with clear cell carcinoma and tumor-associated thrombosis.
    Cuff J; Salari K; Clarke N; Esheba GE; Forster AD; Huang S; West RB; Higgins JP; Longacre TA; Pollack JR
    PLoS One; 2013; 8(9):e74562. PubMed ID: 24040285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12.
    Sun J; Zheng SL; Wiklund F; Isaacs SD; Purcell LD; Gao Z; Hsu FC; Kim ST; Liu W; Zhu Y; Stattin P; Adami HO; Wiley KE; Dimitrov L; Sun J; Li T; Turner AR; Adams TS; Adolfsson J; Johansson JE; Lowey J; Trock BJ; Partin AW; Walsh PC; Trent JM; Duggan D; Carpten J; Chang BL; Grönberg H; Isaacs WB; Xu J
    Nat Genet; 2008 Oct; 40(10):1153-5. PubMed ID: 18758462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HNF1B polymorphism associated with development of prostate cancer in Korean patients.
    Kim HJ; Bae JS; Lee J; Chang IH; Kim KD; Shin HD; Han JH; Lee SY; Kim W; Myung SC
    Urology; 2011 Oct; 78(4):969.e1-6. PubMed ID: 21982019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of association of HNF1B variants with diverse cancers: collaborative analysis of data from 19 genome-wide association studies.
    Elliott KS; Zeggini E; McCarthy MI; Gudmundsson J; Sulem P; Stacey SN; Thorlacius S; Amundadottir L; Grönberg H; Xu J; Gaborieau V; Eeles RA; Neal DE; Donovan JL; Hamdy FC; Muir K; Hwang SJ; Spitz MR; Zanke B; Carvajal-Carmona L; Brown KM; ; Hayward NK; Macgregor S; Tomlinson IP; Lemire M; Amos CI; Murabito JM; Isaacs WB; Easton DF; Brennan P; ; Barkardottir RB; Gudbjartsson DF; Rafnar T; Hunter DJ; Chanock SJ; Stefansson K; Ioannidis JP
    PLoS One; 2010 May; 5(5):e10858. PubMed ID: 20526366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells.
    Cardenas H; Vieth E; Lee J; Segar M; Liu Y; Nephew KP; Matei D
    Epigenetics; 2014 Nov; 9(11):1461-72. PubMed ID: 25470663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive germline-somatic interplay contributes to prostate cancer progression through HNF1B co-option of TMPRSS2-ERG.
    Giannareas N; Zhang Q; Yang X; Na R; Tian Y; Yang Y; Ruan X; Huang D; Yang X; Wang C; Zhang P; Manninen A; Wang L; Wei GH
    Nat Commun; 2022 Nov; 13(1):7320. PubMed ID: 36443337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression, Epigenetic, and Genetic Changes of HNF1B in Colorectal Lesions: an Analysis of 145 Cases.
    Bártů M; Hojný J; Hájková N; Michálková R; Krkavcová E; Simon K; Frýba V; Stružinská I; Němejcová K; Dundr P
    Pathol Oncol Res; 2020 Oct; 26(4):2337-2350. PubMed ID: 32488808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis.
    Grisanzio C; Werner L; Takeda D; Awoyemi BC; Pomerantz MM; Yamada H; Sooriakumaran P; Robinson BD; Leung R; Schinzel AC; Mills I; Ross-Adams H; Neal DE; Kido M; Yamamoto T; Petrozziello G; Stack EC; Lis R; Kantoff PW; Loda M; Sartor O; Egawa S; Tewari AK; Hahn WC; Freedman ML
    Proc Natl Acad Sci U S A; 2012 Jul; 109(28):11252-7. PubMed ID: 22730461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of prostate cancer risk variants rs10993994 and rs7098889 by CRISPR/Cas9 mediated genome editing.
    Wang X; Hayes JE; Xu X; Gao X; Mehta D; Lilja HG; Klein RJ
    Gene; 2021 Feb; 768():145265. PubMed ID: 33122083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.